General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Direct Share Purchase Plan

Directives for the Novartis Direct Share Purchase Plan

For step-by-step instructions on how to apply for and participate in the Novartis Direct Share Purchase Plan, download the document below.

Application to Participate in the Novartis Direct Share Purchase Plan

If you do not yet own shares of Novartis stock, you may enroll in the plan by completing an application to participate in the Novartis Direct Share Purchase Plan and reading the directives and the regulations for the Direct Share Purchase Plan.

Order to a bank to deliver Novartis Shares from a Deposit Account

Stock Market Sale Order (Order to sell at best)

Stock chart